Security key
890260201
TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP)
CUSIP: 890260201
Q4 2016 13F Holders as of 31 Dec 2016
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 2,775,463
- Total 13F value
- $1,302,258
- Share change
- -1,216,547
- SEC-reported price per share
- $0.47
- Number of holders
- 23
- Value change
- -$775,371
- Number of buys
- 8
- Number of sells
- 20
Report period
Q4 2016
Institutions
23
Top holders
10
TNXP full security history
Ownership snapshot
Full 13F holder table
Tonix Pharmaceuticals Holding Corp. SEC filings
Tonix Pharmaceuticals Holding Corp. company facts
Broader feeds
Ownership snapshot
Top reported holders of TNXP - TONIX PHARMACEUTICALS HLDG C - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
KINGDON CAPITAL MANAGEMEN...
Disclosed value leader
KINGDON CAPITAL MANAGEMEN...
Comparable rows
0/15
Latest evidence
30 Sep 2016
13F
Highest disclosed value: $856,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
KINGDON CAPITAL MANAGEMENT, L.L.C. has the largest disclosed position value at $856K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens KINGDON CAPITAL MANAGEMENT, L.L.C.'s linked filing trail.
Disclosed position value
Top 5
KINGDON CAPITAL MANAGEMENT, L.L.C.
$856K
VANGUARD GROUP INC
$542K
RENAISSANCE TECHNOLOGIES LLC
$259K
CITADEL ADVISORS LLC
$151K
SABBY MANAGEMENT, LLC
$142K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
Company
|
—
denominator unverified
|
$856,000
1,227,832 shares
|
— | 30 Sep 2016 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$542,000
777,440 shares
|
— | 30 Sep 2016 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$259,000
371,705 shares
|
— | 30 Sep 2016 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$151,000
216,358 shares
|
— | 30 Sep 2016 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$142,000
203,097 shares
|
— | 30 Sep 2016 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
—
denominator unverified
|
$82,000
117,591 shares
|
— | 30 Sep 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2016
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
23
Shares
2,775,463
Rows available
23
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
33
Q4 2016 holders
23
Holder diff
-10
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 value | Q4 2016 value | Value change | Value Chg % |
|---|